Answers are grounded in this paper and cite their sources.
This analysis shows the antifungal efficacy of copper oxide nanoparticles against Candida species, suggesting a novel treatment for drug-resistant strains.
A BSTRACT Introduction: Recurrent vaginal infections caused by Candida species, particularly drug-resistant strains, remain a major concern in women’s reproductive health. Aim: This study evaluates the antifungal potential of copper oxide nanoparticles (CuO NPs), synthesized via a semi-solvothermal method, against clinically relevant vaginal Candida species— Candida albicans, C. glabrata, C. tropicalis , and C. krusei . Materials and methods: Structural and optical characterization confirmed a crystalline cubic phase (XRD), a strong UV–Vi’s absorption at 340 nm with a 3.4 eV band gap, and spherical nanoparticles (10–25 nm) seen via FESEM. Antifungal activity was tested using agar well diffusion and CFU assays across 15–1000 μg/mL concentrations. Result: A concentration-dependent colony forming unit (CFU) reduction was observed, with C. krusei showing the highest sensitivity (MIC: 60 μg/mL; complete inhibition at 1000 μg/mL), followed by C. glabrata. C. albicans and C. tropicalis exhibited moderate to high resistance. Conclusion: These findings highlight the potential of CuO NPs as a promising antifungal agent, particularly effective against resistant or non- albicans Candida species, offering an alternative strategy for treating vaginal candidiasis.
No takes yet. Share an insight, caveat, or question.
Zende et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: